GlassScriptPhysician profile
Caleb Paul Thomas
NPI 1578182812
$2,728.79
in general payments reported to CMS, 2019-2025
17 companies · $672 in 2025
The $672 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $938 · 2024: $1,119 · 2025: $672.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,662 · Travel and Lodging: $1,067.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,662.12 |
| Travel and Lodging | $1,066.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $901.67 | 2023 | Prostep, Biofoam, Infinity |
| Paragon 28, INC. | $885.80 | 2024-2025 | Portfolio, Grappler, Precision Mis Bunion |
| Smith+Nephew, INC. | $215.73 | 2024-2025 | Grafix Pl, Renasys Go V2 Home, Grafix |
| Medtronic, INC. | $188.52 | 2024-2025 | Intellis Adaptivestim |
| Invictus Surgical Incorporated | $159.73 | 2024-2025 | |
| Fusion Orthopedics USA, LLC | $67.84 | 2025 | |
| Treace Medical Concepts, INC. | $63.62 | 2024 | |
| Nevro Corp. | $51.66 | 2024 | Senza |
| Novus Surgical Consultants | $36.10 | 2023 | |
| Globus Medical, INC. | $28.34 | 2025 | Senza |
| Organogenesis INC. | $27.37 | 2024 | |
| Fidia Pharma USA INC. | $25.23 | 2024 | Hyalgan, Hymovis, Triluron |
| Mimedx Group, INC. | $20.38 | 2025 | |
| Orthofix Medical, INC. | $19.03 | 2024 | Physio-Stim |
| Biowound Solutions, INC. | $17.17 | 2025 | Bio-Connekt |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $15.25 | 2025 | Nuzyra |
| Reprise Biomedical, INC. | $5.35 | 2024 | Miro3d |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caleb Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.